{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:12:08Z","timestamp":1794323528790,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ethiopian Public Health Institute"},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Access Bio-Ethiopia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Glucose-6-phosphate dehydrogenase (G6PD) is cytosolic enzyme, which has a vital role for the integrity and functioning of red blood cells. Lower activity of this enzyme leads to the occurrence of acute haemolytic anaemia after exposure to oxidative stressors like primaquine. Primaquine is an important drug for the radical cure of\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      and blocking transmission of\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      , and thereby enhancing malaria elimination. However, there is a need to identify G6PD deficient individuals and administer the drug with caution due to its haemolytic side effects. The main objective of this study is to determine the prevalence of G6PD deficiency among malaria-suspected individuals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A facility-based cross-sectional study was conducted from September 2020 to September 2021 in Metehara Health Centre, Eastern Ethiopia. A structured questionnaire was used to collect the socio-demographic and clinical information of the study participants. Capillary and venous blood samples were collected based on standard procedures for onsite screening, dried blood spot preparation, and malaria microscopy. The G6PD enzyme activity was measured by careSTART\u2122 G6PD biosensor analyzer. Data was entered and analysed by SPSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 498 study participants were included in the study, of which 62% (309) were males. The overall prevalence of G6PD deficiency based on the biosensor screening was 3.6% (18\/498), of which 2.9% and 4.8% were males and females, respectively. Eleven of the G6PD deficient samples had mutations confirmed by G6PD gene sequencing analysis. Mutations were detected in G267\u2009+\u2009119C\/T, A376T, and ChrX:154535443. A significant association was found in sex and history of previous malaria infection with G6PD deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study showed that the G6PD deficient phenotype exists in Metehara even if the prevalence is not very high. G267\u2009+\u2009119C\/T mutation is the predominant G6PD variant in this area. Therefore, malaria patient treatment using primaquine should be monitored closely for any adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-022-04269-5","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T10:03:07Z","timestamp":1662631387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-0456","authenticated-orcid":false,"given":"Tassew Tefera","family":"Shenkutie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn","family":"Nega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kepple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshesha Tsigie","family":"Negash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderaw","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shewayiref Geremew","family":"Gebremichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokretsion","family":"Gidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindew M.","family":"Feleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u201378.","journal-title":"Blood Cells Mol Dis"},{"key":"4269_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"4269_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2019.105252","volume":"202","author":"RS Bharti","year":"2020","unstructured":"Bharti RS, Vashisht K, Ahmed N, Nayak A, Pande V, Mishra N. First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in silico. Acta Trop. 2020;202: 105252.","journal-title":"Acta Trop"},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-6788-9_1","volume":"1560","author":"AL Peters","year":"2017","unstructured":"Peters AL, van Noorden CJ. Single cell cytochemistry illustrated by the demonstration of glucose-6-phosphate dehydrogenase deficiency in erythrocytes. Methods Mol Biol. 2017;1560:3\u201313.","journal-title":"Methods Mol Biol"},{"key":"4269_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12936-016-1343-1","volume":"15","author":"SH Valencia","year":"2016","unstructured":"Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Ar\u00e9valo-Herrera M. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia. Malar J. 2016;15:291.","journal-title":"Malar J"},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1871529X11313010008","volume":"13","author":"G Manganelli","year":"2013","unstructured":"Manganelli G, Masullo U, Passarelli S, Filosa S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc Hematol Disord Drug Targets. 2013;13:73\u201382.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"4269_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134593","volume":"10","author":"Q Li","year":"2015","unstructured":"Li Q, Yang F, Liu R, Luo L, Yang Y, Zhang L, et al. Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency at the China-Myanmar border. PLoS ONE. 2015;10: e0134593.","journal-title":"PLoS ONE"},{"key":"4269_CR8","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2016.029","volume":"8","author":"AK Ouattara","year":"2016","unstructured":"Ouattara AK, Yameogo P, Diarra B, Obiri-Yeboah D, Yonli A, Compaore TR, et al. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Burkina Faso: G-6-PD betica selma and santamaria in people with symptomatic malaria in Ouagadougou. Mediterr J Hematol Infect Dis. 2016;8: e2016029.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/vox.12068","volume":"105","author":"RO Francis","year":"2013","unstructured":"Francis RO, Jhang JS, Pham HP, Hod EA, Zimring JC, Spitalnik SL. Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks. Vox Sang. 2013;105:271\u201382.","journal-title":"Vox Sang"},{"key":"4269_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171208","volume":"12","author":"S Gunawardena","year":"2017","unstructured":"Gunawardena S, Kapilananda G, Samarakoon D, Maddevithana S, Wijesundera S, Goonaratne LV, et al. Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka. PLoS ONE. 2017;12: e0171208.","journal-title":"PLoS ONE"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12936-019-2688-z","volume":"18","author":"NSG Gueye","year":"2019","unstructured":"Gueye NSG, Peko SM, Nderu D, Koukouikila-Koussounda F, Vouvoungui C, Kobawila SC, et al. An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo. Malar J. 2019;18:57.","journal-title":"Malar J"},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14503\/THIJ-16-6052","volume":"45","author":"JE Thomas","year":"2018","unstructured":"Thomas JE, Kang S, Wyatt CJ, Kim FS, Mangelsdorff AD, Weigel FK. Glucose-6-Phosphate dehydrogenase deficiency is associated with cardiovascular disease in US Military centers. Tex Heart Inst J. 2018;45:144\u201350.","journal-title":"Tex Heart Inst J"},{"key":"4269_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004558","volume":"6","author":"SS Ahmad","year":"2021","unstructured":"Ahmad SS, Rahi M, Sharma A. Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India? BMJ Glob Health. 2021;6: e004558.","journal-title":"BMJ Glob Health"},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40249-021-00896-3","volume":"10","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang L, Xia Z, Zhou H, Huang F. Epidemiological characterization of imported recurrent Plasmodium vivax and Plasmodium ovale in China, 2013\u20132020. Infect Dis Poverty. 2021;10:113.","journal-title":"Infect Dis Poverty"},{"key":"4269_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pt.2010.08.005","volume":"27","author":"JK Baird","year":"2011","unstructured":"Baird JK, Surjadjaja C. Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2011;27:11\u20136.","journal-title":"Trends Parasitol"},{"key":"4269_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12936-017-1864-2","volume":"16","author":"P Ghimire","year":"2017","unstructured":"Ghimire P, Singh N, Ortega L, Rijal KR, Adhikari B, Thakur GD, et al. Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal. Malar J. 2017;16:214.","journal-title":"Malar J"},{"key":"4269_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.696598","volume":"11","author":"JK Baird","year":"2021","unstructured":"Baird JK. Basic research of Plasmodium vivax biology: enabling its management as a clinical and public health problem. Front Cell Infect Microbiol. 2021;11: 696598.","journal-title":"Front Cell Infect Microbiol"},{"key":"4269_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12936-018-2538-4","volume":"17","author":"A Assefa","year":"2018","unstructured":"Assefa A, Ali A, Deressa W, Tsegaye W, Abebe G, Sime H, et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. Malar J. 2018;17:388.","journal-title":"Malar J"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4269\/ajtmh.17-0557","volume":"98","author":"TE Carter","year":"2018","unstructured":"Carter TE, Mekonnen SK, Lopez K, Bonnell V, Damodaran L, Aseffa A, et al. Glucose-6-phosphate dehydrogenase deficiency genetic variants in malaria patients in Southwestern Ethiopia. Am J Trop Med Hyg. 2018;98:83\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"4269_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12936-019-2981-x","volume":"18","author":"E Lo","year":"2019","unstructured":"Lo E, Zhong D, Raya B, Pestana K, Koepfli C, Lee M-C, et al. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia. Malar J. 2019;18:340.","journal-title":"Malar J"},{"key":"4269_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12936-018-2437-8","volume":"17","author":"G Shitaye","year":"2018","unstructured":"Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, et al. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches. Malar J. 2018;17:281.","journal-title":"Malar J"},{"key":"4269_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001891","volume":"12","author":"LJ Robinson","year":"2015","unstructured":"Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, et al. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model. PLoS Med. 2015;12: e1001891.","journal-title":"PLoS Med."},{"key":"4269_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/wellcomeopenres.13373.1","volume":"3","author":"L Thielemans","year":"2018","unstructured":"Thielemans L, Gornsawun G, Hanboonkunupakarn B, Paw MK, Porn P, Moo PK, et al. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: a cohort study. Wellcome Open Res. 2018;3:1.","journal-title":"Wellcome Open Res"},{"key":"4269_CR24","first-page":"601","volume":"67","author":"Working Group","year":"1989","unstructured":"Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601\u201311.","journal-title":"Bull World Health Organ"},{"key":"4269_CR25","volume-title":"A framework for malaria elimination","author":"WHO","year":"2017","unstructured":"WHO. A framework for malaria elimination. Geneva: World Health Organization; 2017."},{"key":"4269_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154618","volume":"11","author":"D Nega","year":"2016","unstructured":"Nega D, Assefa A, Mohamed H, Solomon H, Woyessa A, Assefa Y, et al. Therapeutic efficacy of artemether-lumefantrine (Coartem\u00ae) in treating uncomplicated P. falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study. PLoS ONE. 2016;11: e0154618.","journal-title":"PLoS ONE"},{"key":"4269_CR27","volume-title":"Guidelines on drawing blood: best practices in phlebotomy","author":"WHO","year":"2010","unstructured":"WHO. Guidelines on drawing blood: best practices in phlebotomy. Geneva: World Health Organization; 2010."},{"key":"4269_CR28","volume-title":"Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO evidence review group meeting report","author":"WHO","year":"2014","unstructured":"WHO. Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria. WHO evidence review group meeting report. Geneva: World Health Organization; 2014."},{"key":"4269_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226927","volume":"14","author":"P Pengboon","year":"2019","unstructured":"Pengboon P, Thamwarokun A, Changsri K, Kaset C, Chomean S. Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection. PLoS ONE. 2019;14: e0226927.","journal-title":"PLoS ONE"},{"key":"4269_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40249-021-00889-2","volume":"10","author":"OKM Djigo","year":"2021","unstructured":"Djigo OKM, Khalef YO, Salem MSOA, Gomez N, Basco L, Briolant S, et al. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania. Infect Dis Poverty. 2021;10:105.","journal-title":"Infect Dis Poverty"},{"key":"4269_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169930","volume":"12","author":"B Ley","year":"2017","unstructured":"Ley B, Alam MS, O\u2019Donnell JJ, Hossain MS, Kibria MG, Jahan N, et al. A comparison of three quantitative methods to estimate G6PD activity in the Chittagong Hill Tracts, Bangladesh. PLoS ONE. 2017;12: e0169930.","journal-title":"PLoS ONE"},{"key":"4269_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206331","volume":"13","author":"MS Alam","year":"2018","unstructured":"Alam MS, Kibria MG, Jahan N, Thriemer K, Hossain MS, Douglas NM, et al. Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity. PLoS ONE. 2018;13: e0206331.","journal-title":"PLoS ONE"},{"key":"4269_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4269\/ajtmh.16-0714","volume":"97","author":"TA Weppelmann","year":"2017","unstructured":"Weppelmann TA, von Fricken ME, Wilfong TD, Aguenza E, Philippe TT, Okech BA. Field trial of the CareStart biosensor analyzer for the determination of glucose-6-phosphate dehydrogenase activity in Haiti. Am J Trop Med Hyg. 2017;97:1262.","journal-title":"Am J Trop Med Hyg"},{"key":"4269_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12936-017-2017-3","volume":"16","author":"B Ley","year":"2017","unstructured":"Ley B, Bancone G, Von Seidlein L, Thriemer K, Richards JS, Domingo GJ, et al. Methods for the field evaluation of quantitative G6PD diagnostics: a review. Malar J. 2017;16:361.","journal-title":"Malar J"},{"key":"4269_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009649","volume":"15","author":"S Zobrist","year":"2021","unstructured":"Zobrist S, Brito M, Garbin E, Monteiro WM, Clementino Freitas S, Macedo M, et al. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil. PLoS Negl Trop Dis. 2021;15: e0009649.","journal-title":"PLoS Negl Trop Dis"},{"key":"4269_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12936-016-1396-1","volume":"15","author":"CN Nguetse","year":"2016","unstructured":"Nguetse CN, Meyer CG, Adegnika AA, Agbenyega T, Ogutu BR, Kremsner PG, et al. Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria. Malar J. 2016;15:346.","journal-title":"Malar J"},{"key":"4269_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/1475-2875-13-438","volume":"13","author":"A Tsegaye","year":"2014","unstructured":"Tsegaye A, Golassa L, Mamo H, Erko B. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia. Malar J. 2014;13:438.","journal-title":"Malar J"},{"key":"4269_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12936-018-2510-3","volume":"17","author":"N Kie\u00dfling","year":"2018","unstructured":"Kie\u00dfling N, Brintrup J, Zeynudin A, Abduselam N, G\u00f6tz S, Mack M, et al. Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia. Malar J. 2018;17:358.","journal-title":"Malar J"},{"key":"4269_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257562","volume":"16","author":"LE Amoah","year":"2021","unstructured":"Amoah LE, Asare KK, Dickson D, Abankua J, Busayo A, Bredu D, et al. Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana. PLoS ONE. 2021;16: e0257562.","journal-title":"PLoS ONE"},{"key":"4269_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12936-016-1674-y","volume":"16","author":"B Galatas","year":"2017","unstructured":"Galatas B, Mabote L, Simone W, Matambisso G, Nhamussua L, Del Mar M-P, et al. Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions. Malar J. 2017;16:36.","journal-title":"Malar J"},{"key":"4269_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12879-018-3031-y","volume":"18","author":"J Lee","year":"2018","unstructured":"Lee J, Im Kim T, Kang J-M, Jun H, Le HG, Thai TL, et al. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar. BMC Infect Dis. 2018;18:131.","journal-title":"BMC Infect Dis"},{"key":"4269_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.11604\/pamj.2018.31.46.16527","volume":"31","author":"YG Tseghereda","year":"2018","unstructured":"Tseghereda YG, Nganga JK, Kimang\u2019a AN, Mehari TH, Weldemichael YG. Glucose-6-phosphate dehydrogenase deficiency allelic variants and their prevalence in malaria patients in Eritrea. Pan Afr Med J. 2018;31:46.","journal-title":"Pan Afr Med J"},{"key":"4269_CR43","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/ijms17122069","volume":"17","author":"S G\u00f3mez-Manzo","year":"2016","unstructured":"G\u00f3mez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, Gonz\u00e1lez-Valdez A, et al. Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world. Int J Mol Sci. 2016;17:2069.","journal-title":"Int J Mol Sci"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04269-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:27:45Z","timestamp":1662640065000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04269-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04269-5","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board (IRB) of Addis Ababa University and the IRB of EPHI. The purpose of the study was explained and written informed consent was obtained from each study participants. Participants with malaria infection were treated immediately based on the national malaria treatment guideline free of charge in the study facility. All personal information was kept confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"260"}}